Trial Profile
Pilot Study of OXP005 to Assess Gastroduodenal Irritation
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Jun 2015
Price :
$35
*
At a glance
- Drugs Naproxen (Primary)
- Indications Musculoskeletal pain
- Focus Adverse reactions
- Sponsors Oxford Pharmascience
- 17 Jun 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jun 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 May 2015 Status changed from not yet recruiting to recruiting, according to an Oxford Pharmascience media release.